Hepatitis B and C are viruses that infect the liver and can silently progress to become serious diseases such as cirrhosis and liver cancer. Effective antiviral treatment is available and timely treatment of eligible patients can prevent hepatitis-related burden of disease and death. The main...

The global burden of disease due to hepatitis B and C virus infection is high, and chronic infection with these viruses can lead to cirrhosis, liver failure and hepatocellular carcinoma. Effective treatments exist for both chronic hepatitis B and C; however, the treatment regimen to be given for...

A Council Recommendation dated 15 November 2001 on the prudent use of antimicrobial agents in human medicine (2002/77/EC) outlines the threat that AMR poses to human health and advocates a range of actions to be taken for its prevention and control. Council Conclusions on antimicrobial...

The ECDC guidance on integrated testing of hepatitis B (HBV), hepatitis C (HCV) and HIV supports countries in the global effort to combat viral hepatitis and eliminate HIV as public health threats by 2030. At present, reaching and testing those at risk of infection with HIV, HBV or HCV is still...